Medbright Ai Invts Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Yam-Chung Chu
- Full Time Employees
- 366
- Sector
- Consumer Defensive
- Industry
- Education & Training Services
- Address
- 777 Broadway West Vancouver BC Canada V5Z 4J7
- IPO Date
- Oct 2, 2007
- Website
- cibt.net
- Similar Companies
- Business
- MedBright AI Investments Inc. is an investment issuer focusing primarily on healthcare technology companies, operating at the intersection of healthcare and technology. The company specializes in deploying artificial intelligence and machine learning solutions aimed at empowering medical professionals, enhancing clinical operations, reducing healthcare costs, and improving patient outcomes. Among its core offerings is the MedMatrix AI platform, designed for commercial product demonstrations and healthcare data analytics. MedBright's investments include diverse technologies, with a strategic focus on near-term and midterm high-quality opportunities in healthcare and artificial intelligence sectors. The company also engages in capital allocation across public and private companies in technology, healthcare, and AI industries. Founded with headquarters in Vancouver, British Columbia, Canada, MedBright AI underwent a significant transformation when it changed its name from Vinergy Capital Inc. in November 2023, reflecting its focused commitment to AI-driven healthcare ventures. Recently, MedBright AI has made notable strategic advances, including a $900,000 investment in Algo8 Industrial AI Inc., a company specializing in AI technologies for industrial automation and sustainability, with operations spanning India, UAE, UK, Netherlands, the US, and Canada. This investment underscores MedBright's intent to advance AI-driven industrial transformation and autonomous factory applications. Additionally, in mid-2024, MedBright AI agreed to a strategic acquisition by Numinus Wellness Inc., which plans to rebrand the business as Numinus Intelligence. This merger aims to combine MedBright’s AI-enabled clinical solutions with Numinus’ expertise in behavioral and psychedelic-assisted mental health therapies across the U.S., enhancing clinical efficiency and expanding reimbursable service offerings. MedBright AI also delivers healthcare technology services such as AI-powered reporting and market expansion tools, exemplified by its partnerships with medical groups and clinics in Canada and Southern California. These partnerships help streamline reporting, improve operations, and support the opening of new clinic locations using AI-enabled market insights. The company maintains an active role in investor relations and continuous disclosure management, aiming to drive operational efficiency and revenue growth through technology and strategic alliances across North America. In summary, MedBright AI Investments Inc. operates as a capital allocator and AI technology provider focused on healthcare and industrial automation sectors, delivering AI platforms and investing in innovative companies globally. Its key recent developments include the strategic investment in Algo8 Industrial AI, the planned acquisition by Numinus Wellness with a rebranding initiative to Numinus Intelligence, and expanding its AI applications in clinical and market operations within North America. MedBright AI is headquartered in Vancouver, Canada, and trades on Canadian and U.S. markets under the ticker MBAI/MBAIF.
MedBright AI Investments Inc. Announces Name Change and Amended Investment Policy
Algo8 Announces Successful Scaling of AI-Powered Process Optimization and Safety with a Global Automotive Component Manufacturer
MedBright AI Announces Termination of Limmi Agreements
MedBright AI Appointments Brandon Kou as Director
MedBright AI Announces the Appointment of Christopher Heath as CEO and Termination of Letter of Intent
MedBright AI Issues Clarifying News Release on Continuous Disclosure Record
MedBright AI Announces Strategic Acquisition by Numinus Wellness
Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform
Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations
MedBright AI Announces Investor Relations Agreement with Anthem Strategies Ltd.
MedMatrix Go-to-Market Pricing Announced for AI Product Suite Addressing US$726 Billion Market
MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite
MedBright AI Announces Limmi Disease Insights Platform Being Used in University Hospital Setting to Improve Detection of Kidney Stone Disease Recurrence
MedBright AI Announces Closing of LIFE Offering for Gross Proceeds of Approximately $1.4 Million
MedBright AI to Present at CEM Bahamas Small-Cap Conference and Maxim Group's 2024 Healthcare IT Conference
MedBright AI Reaches US$100M in Total Clinic Revenue Under Contract with MedMatrix, the AI-Powered Data Analytics Platform
MedBright AI Investments Inc. Responds to OTC Markets Request on Recent Promotional Activity
MedBright AI Announces Rejuvenation Medical Group, a Large Canadian Clinic Group, as First International Customer for MedMatrix, the AI-Driven Data and Analytics Platform
MedBright AI Announces Closing of Investment in Limmi Healthcare AI Platform
MedBright AI Announces CareMEDICA, a Yale University School of Medicine Affiliated Clinic Group, as Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform